Yifeng Pharmacy Chain (603939) Q3 2024 earnings summary

Executive summary

• Revenue for the first nine months of 2024 reached RMB 17.22 billion, up 8.38% year-over-year.

• Net profit attributable to shareholders was RMB 1.11 billion, an increase of 11.14% year-over-year.

• The company added 2,254 new stores (net increase of 1,800) in the first nine months, bringing the total to 15,050.

• Completed two major acquisitions, expanding presence in Hebei and Hubei provinces.

Financial highlights

• Q3 revenue was RMB 5.46 billion, up 5.31% compared to the same quarter last year.

• Q3 net profit attributable to shareholders was RMB 312.78 million, up 6.38% year-over-year.

• Operating cash flow for the first nine months was RMB 3.34 billion, up 15.96% year-over-year.

• Basic and diluted EPS for the first nine months was RMB 0.92, up 10.84% year-over-year.

• Total assets at quarter-end were RMB 27.21 billion, up 12.74% from the end of last year.

Outlook and guidance

• Continued expansion through new store openings and targeted acquisitions.

• Focus on integrating acquired businesses and optimizing operational efficiency.